ABLYNX Stock Price, News & Analysis (OTCMKTS:ABLYF)

$23.98 0.13 (0.55 %)
(As of 12/15/2017 04:00 PM ET)
Previous Close$23.98
Today's Range$23.98 - $23.98
52-Week Range$10.75 - $50.00
Volume1,087 shs
Average Volume293 shs
Market Capitalization$1.78 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About ABLYNX (OTCMKTS:ABLYF)

ABLYNX logoAblynx NV, a biopharmaceutical company, develops Nanobodies that is a proprietary therapeutic protein based on single-domain antibody fragments for the treatment of various diseases. The company develops products in various therapeutic areas, such as inflammation, hematology, immuno-oncology, oncology, and respiratory diseases. Its clinical programs include caplacizumab, an anti-vWF Nanobody that is in Phase III clinical trial to treat acquired thrombotic thrombocytopenic purpura; ALX-0171, an anti-RSV Nanobody, which is in Phase IIb clinical trial for the treatment of respiratory syncytial virus (RSV) infection; and Vobarilizumab, an anti-IL-6R Nanobody that is in Phase IIb clinical trial for the treatment of rheumatoid arthritis, as well as in Phase II clinical trial to treat systemic lupus erythematosus. The company is also developing ALX-0761, which is in Phase Ib clinical trial for the treatment of psoriasis, as well as auto-immune disorders; ozoralizumab, which is in a Phase IIa clinical trial for the treatment of auto-immune disorders with focus on rheumatoid arthritis; and ALX-0141, a trivalent Nanobody for the treatment of bone related disorders, including osteoporosis and bone metastases, as well as completed a Phase I study in post-menopausal women. Ablynx NV has collaborations with AbbVie, Boehringer Ingelheim, Eddingpharm, Merck & Co., Inc., Merck KGaA, Novartis, Novo Nordisk, and Taisho Pharmaceuticals. It also has a research collaboration and licensing agreement with Sanofi for developing and commercializing Nanobody(R)-based therapeutics for the treatment of various immune-mediated inflammatory diseases. The company was formerly known as MatchX and changed its name to Ablynx NV in June 2002. Ablynx NV was founded in 2001 and is headquartered in Ghent, Belgium.

Receive ABLYF News and Ratings via Email

Sign-up to receive the latest news and ratings for ABLYF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:ABLYF
CUSIPN/A
Phone329-262-0000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$94.28 million
Price / Sales19.00
Cash Flow$0.02 per share
Price / Cash1,140.69
Book Value$1.87 per share
Price / Book12.82

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees329
Outstanding Shares74,720,000

ABLYNX (OTCMKTS:ABLYF) Frequently Asked Questions

What is ABLYNX's stock symbol?

ABLYNX trades on the OTCMKTS under the ticker symbol "ABLYF."

Where is ABLYNX's stock going? Where will ABLYNX's stock price be in 2017?

1 Wall Street analysts have issued 12-month price targets for ABLYNX's stock. Their forecasts range from $26.00 to $26.00. On average, they expect ABLYNX's stock price to reach $26.00 in the next twelve months. View Analyst Ratings for ABLYNX.

Who are some of ABLYNX's key competitors?

How do I buy ABLYNX stock?

Shares of ABLYNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ABLYNX's stock price today?

One share of ABLYNX stock can currently be purchased for approximately $23.98.

How big of a company is ABLYNX?

ABLYNX has a market capitalization of $1.78 billion and generates $94.28 million in revenue each year. ABLYNX employs 329 workers across the globe.

How can I contact ABLYNX?

ABLYNX's mailing address is TECHNOLOGIEPARK 21 ZWIJNAARDE, GHENT C9, 9052. The company can be reached via phone at 329-262-0000.


MarketBeat Community Rating for ABLYNX (ABLYF)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  11 (Vote Outperform)
Underperform Votes:  8 (Vote Underperform)
Total Votes:  19
MarketBeat's community ratings are surveys of what our community members think about ABLYNX and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

ABLYNX (OTCMKTS:ABLYF) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyN/AN/A
Consensus Rating Score: 3.003.00N/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $26.00$26.00N/AN/A
Price Target Upside: 25.60% upside25.60% upsideN/AN/A

ABLYNX (OTCMKTS:ABLYF) Consensus Price Target History

Price Target History for ABLYNX (OTCMKTS:ABLYF)

ABLYNX (OTCMKTS:ABLYF) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
11/10/2017Bank of AmericaInitiated CoverageBuy$26.00View Rating Details
(Data available from 12/16/2015 forward)

Earnings

Earnings History for ABLYNX (OTCMKTS:ABLYF)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

ABLYNX (OTCMKTS:ABLYF) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.09 EPS
Next Year EPS Consensus Estimate: $-1.04 EPS

Dividends

Dividend History for ABLYNX (OTCMKTS:ABLYF)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ABLYNX (OTCMKTS ABLYF)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

ABLYNX (OTCMKTS ABLYF) News Headlines

Source:
DateHeadline
ABLYNX WILL HOST A WEBCAST TO DISCUSS ADDITIONAL DATA FROM ITS PHASE III HERCULES STUDY OF CAPLACIZUMAB IN ACQUIRED TTP FOLLOWING ASH LATE-BREAKING DATA PRESENTATIONABLYNX WILL HOST A WEBCAST TO DISCUSS ADDITIONAL DATA FROM ITS PHASE III HERCULES STUDY OF CAPLACIZUMAB IN ACQUIRED TTP FOLLOWING ASH LATE-BREAKING DATA PRESENTATION
feeds.benzinga.com - December 7 at 2:25 AM
Ablynx NV breached its 50 day moving average in a Bullish Manner : ABLYF-US : December 5, 2017Ablynx NV breached its 50 day moving average in a Bullish Manner : ABLYF-US : December 5, 2017
finance.yahoo.com - December 5 at 9:10 AM
Ablynx Nv (ABLYF) Upgraded at Zacks Investment ResearchAblynx Nv (ABLYF) Upgraded at Zacks Investment Research
www.americanbankingnews.com - November 22 at 10:48 PM
Ablynx Nv Expected to Post FY2017 Earnings of ($1.29) Per Share (ABLYF)Ablynx Nv Expected to Post FY2017 Earnings of ($1.29) Per Share (ABLYF)
www.americanbankingnews.com - November 22 at 6:46 AM
Ablynx NV – Value Analysis (US OTC:ABLYF) : October 27, 2017Ablynx NV – Value Analysis (US OTC:ABLYF) : October 27, 2017
finance.yahoo.com - October 27 at 5:32 PM
Ablynx NV breached its 50 day moving average in a Bearish Manner : ABLYF-US : October 26, 2017Ablynx NV breached its 50 day moving average in a Bearish Manner : ABLYF-US : October 26, 2017
finance.yahoo.com - October 26 at 11:39 AM
ETFs with exposure to Ablynx NV : October 26, 2017ETFs with exposure to Ablynx NV : October 26, 2017
finance.yahoo.com - October 26 at 11:39 AM
3 Things In Biotech You Should Learn Today: October 4, 20173 Things In Biotech You Should Learn Today: October 4, 2017
seekingalpha.com - October 5 at 3:13 PM
Ablynx NV breached its 50 day moving average in a Bullish Manner : ABLYF-US : September 28, 2017Ablynx NV breached its 50 day moving average in a Bullish Manner : ABLYF-US : September 28, 2017
finance.yahoo.com - October 2 at 3:13 PM
Ablynx NV breached its 50 day moving average in a Bullish Manner : ABLYF-US : September 15, 2017Ablynx NV breached its 50 day moving average in a Bullish Manner : ABLYF-US : September 15, 2017
finance.yahoo.com - September 15 at 3:27 PM
Ablynx NV breached its 50 day moving average in a Bullish Manner : ABLYF-US : August 28, 2017Ablynx NV breached its 50 day moving average in a Bullish Manner : ABLYF-US : August 28, 2017
finance.yahoo.com - August 28 at 3:28 PM
Ablynx NV :ABLYF-US: Earnings Analysis: For the six months ended June 30, 2017 : August 28, 2017Ablynx NV :ABLYF-US: Earnings Analysis: For the six months ended June 30, 2017 : August 28, 2017
finance.yahoo.com - August 28 at 3:27 PM
Ablynxs (ABLYF) CEO Edwin Moses on Q2 2017 Results - Earnings Call TranscriptAblynx's (ABLYF) CEO Edwin Moses on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 26 at 3:17 PM
Ablynx NV – Value Analysis (US OTC:ABLYF) : August 25, 2017Ablynx NV – Value Analysis (US OTC:ABLYF) : August 25, 2017
finance.yahoo.com - August 25 at 10:02 PM
Ablynx NV breached its 50 day moving average in a Bullish Manner : November 11, 2015Ablynx NV breached its 50 day moving average in a Bullish Manner : November 11, 2015
finance.yahoo.com - August 17 at 12:38 PM
Ablynx NV breached its 50 day moving average in a Bearish Manner : January 18, 2016Ablynx NV breached its 50 day moving average in a Bearish Manner : January 18, 2016
finance.yahoo.com - August 17 at 12:38 PM
Ablynx NV Earnings Analysis: 2015 By the NumbersAblynx NV Earnings Analysis: 2015 By the Numbers
finance.yahoo.com - August 17 at 12:38 PM
Ablynx NV breached its 50 day moving average in a Bearish Manner : ABLYF-US : June 13, 2016Ablynx NV breached its 50 day moving average in a Bearish Manner : ABLYF-US : June 13, 2016
finance.yahoo.com - August 17 at 12:38 PM
Ablynx NV :ABLYF-US: Earnings Analysis: Q1, 2016 By the Numbers : July 12, 2016Ablynx NV :ABLYF-US: Earnings Analysis: Q1, 2016 By the Numbers : July 12, 2016
finance.yahoo.com - August 17 at 12:38 PM
Ablynx NV breached its 50 day moving average in a Bullish Manner : ABLYF-US : December 12, 2016Ablynx NV breached its 50 day moving average in a Bullish Manner : ABLYF-US : December 12, 2016
finance.yahoo.com - August 17 at 12:38 PM
Ablynx NV – Value Analysis (US OTC:ABLYF) : December 13, 2016Ablynx NV – Value Analysis (US OTC:ABLYF) : December 13, 2016
finance.yahoo.com - August 17 at 12:38 PM
Ablynx NV :ABLYF-US: Earnings Analysis: For the six months ended December 31, 2016 : April 7, 2017Ablynx NV :ABLYF-US: Earnings Analysis: For the six months ended December 31, 2016 : April 7, 2017
finance.yahoo.com - August 17 at 12:38 PM
Ablynx NV breached its 50 day moving average in a Bullish Manner : ABLYF-US : May 8, 2017Ablynx NV breached its 50 day moving average in a Bullish Manner : ABLYF-US : May 8, 2017
finance.yahoo.com - August 17 at 12:38 PM
Ablynx NV breached its 50 day moving average in a Bullish Manner : ABLYF-US : August 17, 2017Ablynx NV breached its 50 day moving average in a Bullish Manner : ABLYF-US : August 17, 2017
finance.yahoo.com - August 17 at 12:38 PM
Ablynx Nv (ABLYF) Set to Announce Quarterly Earnings on ThursdayAblynx Nv (ABLYF) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - August 17 at 11:32 AM

SEC Filings

ABLYNX (OTCMKTS:ABLYF) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

ABLYNX (OTCMKTS ABLYF) Stock Chart for Saturday, December, 16, 2017

Loading chart…

This page was last updated on 12/16/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.